A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round. . . . → Read More: Drug Price Disruptor Biotech Raises $500M in New Funds
|
|||||
|
       
  |
A digital health company is partnering with cancer advocacy organizations to provide electronic therapies to help patients deal with stresses from Covid-19. . . . → Read More: Digital Therapeutics Designed for Cancer/Covid-19 Stress 
A current Covid-19 vaccine is shown in lab tests to produce antibodies that appear to protect against new mutations found in South Africa and the U.K. . . . → Read More: Vaccine Shown Active Against New Covid-19 Variants 
Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine. . . . → Read More: CureVac, Bayer Partner on Covid-19 Vaccine Supply  One comment - (Comments are closed)  Joint ventures/collaborations  biomedical, biotechnology, clinical trials, Covid-19, Europe, genomics, life sciences, manufacturing, pharmaceuticals 
A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round. . . . → Read More: Synthetic Biology Company Raises $105M in New Funds One comment - (Comments are closed) Finance biomedical, biotechnology, cancer, engineering, entrepreneurs, equity, Europe, genomics, investment, life sciences, pharmaceuticals, venture capital 
Results of a clinical trial show stem cells from umbilical cord linings help patients with severe respiratory disease recover and survive from Covid-19 infections. . . . → Read More: Stem Cells Help Severe Covid-19 Cases Recover One comment - (Comments are closed) New products biomedical, clinical trials, Covid-19, life sciences, pharmaceuticals, stem cells, university 
A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute. . . . → Read More: Synthetic Virus Company Forms, Raises $77M 2 comments - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, investment, life sciences, pharmaceuticals, preclinical, venture capital 
A biomedical informatics lab developed techniques with artificial intelligence to find new uses for existing drugs from millions of electronic health records. . . . → Read More: AI Process Devised for Drug Repurposing Comments are closed New products biomedical, computer science, heart disease, life sciences, mathematics, medical device, pharmaceuticals, physical sciences, university 
The U.S. Food and Drug Administration issued draft administrative and procedural guidelines for genetic disorders treated with precise gene therapies. . . . → Read More: FDA Issues Precision Genomic Drug Guidance Comments are closed Regulations biomedical, biotechnology, clinical trials, FDA, genomics, life sciences, pharmaceuticals, preclinical, university 
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, entrepreneurs, FDA, genomics, life sciences, manufacturing, pharmaceuticals, stem cells, university |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||